Adverse events60

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 60

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Gastrointestinal Disorders	Gastrointestinal disorders	Optune System Combined With Temozolomide (TMZ) + Pembrolizumab	22	28
other	Gastrointestinal Disorders	Gastrointestinal disorders	Historical Control Optune System Combined With Temozolomide (TMZ)	23	456
other	Blood and Bone Marrow	Blood and lymphatic system disorders	Optune System Combined With Temozolomide (TMZ) + Pembrolizumab	9	28
other	Blood and Bone Marrow	Blood and lymphatic system disorders	Historical Control Optune System Combined With Temozolomide (TMZ)	59	456
other	Infections	Infections and infestations	Optune System Combined With Temozolomide (TMZ) + Pembrolizumab	11	28
other	Infections	Infections and infestations	Historical Control Optune System Combined With Temozolomide (TMZ)	32	456
other	Injury, poisoning and procedural complications	Injury, poisoning and procedural complications	Optune System Combined With Temozolomide (TMZ) + Pembrolizumab	10	28
other	Injury, poisoning and procedural complications	Injury, poisoning and procedural complications	Historical Control Optune System Combined With Temozolomide (TMZ)	24	456
other	Metabolism	Metabolism and nutrition disorders	Optune System Combined With Temozolomide (TMZ) + Pembrolizumab	3	28
other	Metabolism	Metabolism and nutrition disorders	Historical Control Optune System Combined With Temozolomide (TMZ)	16	456
other	Musculoskeletal	Musculoskeletal and connective tissue disorders	Optune System Combined With Temozolomide (TMZ) + Pembrolizumab	19	28
other	Musculoskeletal	Musculoskeletal and connective tissue disorders	Historical Control Optune System Combined With Temozolomide (TMZ)	21	456
other	Nervous System Disorders	Nervous system disorders	Optune System Combined With Temozolomide (TMZ) + Pembrolizumab	21	28
other	Nervous System Disorders	Nervous system disorders	Historical Control Optune System Combined With Temozolomide (TMZ)	109	456
other	Respiratory	Respiratory, thoracic and mediastinal disorders	Optune System Combined With Temozolomide (TMZ) + Pembrolizumab	8	28
other	Respiratory	Respiratory, thoracic and mediastinal disorders	Historical Control Optune System Combined With Temozolomide (TMZ)	24	456
serious	Edema, head and neck	Blood and lymphatic system disorders	Optune System Combined With Temozolomide (TMZ) + Pembrolizumab	1	28
serious	Edema, head and neck	Blood and lymphatic system disorders	Historical Control Optune System Combined With Temozolomide (TMZ)	0	456
serious	Platelets, thrombocytopenia	Blood and lymphatic system disorders	Optune System Combined With Temozolomide (TMZ) + Pembrolizumab	1	28
serious	Platelets, thrombocytopenia	Blood and lymphatic system disorders	Historical Control Optune System Combined With Temozolomide (TMZ)	0	456

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03405792/events

API reference For AI assistants

Adverse events60

Sources 3

Read this list from software.